A multiple dose study of prasugrel (CS‐747), a novel thienopyridine P2Y<sub>12</sub> inhibitor, compared with clopidogrel in healthy humansJoseph A. Jakubowski, Kenneth J. Winters, Stephen Freestone et al.|British Journal of Clinical Pharmacology|2006Cited by 128
Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y<sub>12</sub> inhibitor: A single ascending dose study in healthy humansFumitoshi Asai, Kenneth J. Winters, Joseph A. Jakubowski et al.|Platelets|2006Cited by 108
Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y<sub>12</sub> inhibitor: A multiple-dose study in healthy humansNobuko Matsushima, Kenneth J. Winters, Stephen Freestone et al.|Platelets|2006Cited by 34